Research funding and price negotiation for new drugs (2020), with Izabela Jelovac (University of Lyon, CNRS, GATE), Health Economics 29(S1), 83-96.
Product Differentiation with Multiple Qualities (2018), with Albert Ma (Boston University), International Journal of Industrial Organization 61, 380-412.
Genetic Information: Comparing Alternative Regulatory Approaches when Prevention Matters (2011), joint with Dominique Henriet (Ecole Centrale Marseille, Egim, Idep), Journal of Public Economic Theory 13(1): 23-46.
With A Little Help From My Enemy: Comparative Advertising as a Signal of Quality (2009), joint with Paolo Garella (University of Milan) and Martin Peitz (University of Mannheim); Journal of Economics and Management Strategy 18(4): 1071-1094.
Emotions in Physician Agency (2008), joint with Rosella Levaggi (University of Brescia), Health Policy 88: 1-14.
Comparative Advertising and Competition Policy (2006), joint with Martin Peitz (University of Mannheim), in Recent Developments in Antitrust: Theory and Evidence, edited by Jay Pil Choi, MIT Press, chapter 8: 215-263.
Price vs Quantity in Health Insurance Reimbursement (2006), International Journal of Health Care Finance and Economics 6(3): 191-213.
Supplementary Insurance with Ex-post Moral Hazard: Efficiency and Redistribution (2006), Les Annales d'Economie et de Statistique, N°83-84: 295-325.
Reimbursing Preventive Care (2004), the Geneva Papers on Risk and Insurance Theory 29(2): 165-186.
The Public-Private Mix in Health Insurance (2003), in Antitrust, Regulation and Competition,M.Baldassarri and L.Lambertini eds., Palgrave Macmillan Publishers Ltd for the series: Central Issues in Contemporary Economic Theory & Policy, 217-248.
IN ITALIAN
Sostenibilità del Servizio SanitarioNazionale e Fondi sanitari integrativi: un contributo al dibattito, (2019) with V. Rebba (University of Padova), POLITICHE SANITARIE, 20(1), 2-13.
Assicurazione sanitaria, Rivista di Politica Economica, Settembre-Ottobre 2006, 217-256.